MENU
+Compare
HAE
Stock ticker: NYSE
AS OF
Jul 3 closing price
Price
$76.87
Change
+$0.63 (+0.83%)
Capitalization
4.33B

HAE Haemonetics Corp Forecast, Technical & Fundamental Analysis

Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces... Show more

HAE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for HAE with price predictions
Jul 03, 2025

HAE in downward trend: price may decline as a result of having broken its higher Bollinger Band on June 26, 2025

HAE broke above its upper Bollinger Band on June 26, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options. The A.I.dvisor looked at 35 similar instances where the stock broke above the upper band. In of the 35 cases the stock fell afterwards. This puts the odds of success at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 6 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where HAE declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on June 18, 2025. You may want to consider a long position or call options on HAE as a result. In of 71 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for HAE just turned positive on June 24, 2025. Looking at past instances where HAE's MACD turned positive, the stock continued to rise in of 45 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where HAE advanced for three days, in of 331 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 219 cases where HAE Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. HAE’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.564) is normal, around the industry mean (24.504). P/E Ratio (34.467) is within average values for comparable stocks, (77.706). Projected Growth (PEG Ratio) (1.624) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (3.428) is also within normal values, averaging (43.111).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HAE’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock worse than average.

View a ticker or compare two or three
HAE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

HAE is expected to report earnings to fall 18.55% to $1.01 per share on August 12

Haemonetics Corp HAE Stock Earnings Reports
Q2'25
Est.
$1.01
Q1'25
Beat
by $0.02
Q4'24
Beat
by $0.02
Q3'24
Beat
by $0.05
Q2'24
Beat
by $0.01
The last earnings report on May 08 showed earnings per share of $1.24, beating the estimate of $1.22. With 249.56K shares outstanding, the current market capitalization sits at 4.33B.
A.I. Advisor
published General Information

General Information

a manufacturer of blood processing systems

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
125 Summer Street
Phone
+1 781 848-7100
Employees
3034
Web
https://www.haemonetics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PMVRX19.230.28
+1.48%
Putnam Sustainable Future R
DASVX14.560.11
+0.76%
Dunham Small Cap Value A
AVEDX23.870.18
+0.76%
Ave Maria Rising Dividend
IAUTX27.570.17
+0.62%
Invesco Dividend Income A
SCWCX59.120.34
+0.58%
American Funds SMALLCAP World C

HAE and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, HAE has been loosely correlated with ATR. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if HAE jumps, then ATR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HAE
1D Price
Change %
HAE100%
+0.83%
ATR - HAE
41%
Loosely correlated
+0.45%
CNMD - HAE
41%
Loosely correlated
+0.20%
OM - HAE
39%
Loosely correlated
+1.55%
GH - HAE
38%
Loosely correlated
+0.64%
TMCI - HAE
38%
Loosely correlated
+1.48%
More